A blog about chemistry, drug development, science, and technology
Seems there has been a lot of negative press regarding the pharmaceutical industry lately. One of these is that GlaxoSmithKline has agreed to pay $14 million to 49 states for costs related to Medicaid payments for Paxil. This suit was brought by New York Attorney General Mark Spitzer and the accusation is that Glaxo used fraudulent tactics to delay generic competition. Glaxo also agreed to publicly disclose information from its clinical trials.
Bookmark it with:
|
del.icio.us
|
Digg it
|
Furl
|
Simpy
|
Spurl
|
My Yahoo!
|
[powered by WordPress.]
QDIS: blogging about chemistry, drug development, science and technology.

By Category
Chemistry, science, and technology for the future.

35 queries. 0.778 seconds